Table 4.
Name | OR(95% CI)/SMD(95% CI)* | P -value | ||
---|---|---|---|---|
Direct effect | Indirect effect | Overall | ||
AT,RT | −0.57 (−7.37, 6.43) |
−0.56 (−4.84, 3.75) |
−0.66 (−4.11, 2.79) |
0.98 |
AT,HIIT | −1.25 (−2.87, 0.28) |
0.05 (−3.98, 4.01) |
−1.11 (−2.61, 0.32) |
0.55 |
AT,AT+RT | 0.99 (−2.94, 4.88) |
−1.01 (−6.23, 4.24) |
0.32 (−2.79, 3.39) |
0.53 |
AT,CG | 2.57 (−2.11, 7.25) |
1.81 (−2.01, 5.56) |
2.00 (−0.95, 4.86) |
0.80 |
RT,AT+RT | 1.24 (−5.81, 8.22) |
3.27 (−1.26, 7.77) |
2.65 (−1.43, 6.69) |
0.61 |
RT,CG | 0.25 (−4.89, 5.39) |
2.29 (−1.86, 6.54) |
1.45 (−1.79, 4.56) |
0.53 |
HIIT,CG | 2.54 (−0.66, 5.53) |
5.37 (−1.31, 11.92) |
3.10 (0.38, 5.81)* |
0.43 |
Effectiveness rate was OR (95% CI) and the remaining indicators were SMD (95% CI).